Activation leads to: Increased sebum production , may contribute to acne in some research subjects Changes in sebum composition Pheromone secretion (in animal models) This is a less important mechanism with Melanotan II, but contributes to its non-selective profile
This effect was erased by Ex treatment (post-S1 minus pre-S1, very berry consumed, Ex treatment: +0.11 0.18 mmol/L), which is not surprising given the similar low consumption rates across conditions under the effect of the drug
In contrast, larger linear peptides, such as LL-37 and AW1, may exhibit strong antimicrobial activity but often face challenges related to delivery and stability
Volume: Commonly found in vials of 2 ml or 5 ml
A randomized, double-blind, phase II study of first-line FOLFOX plus bevacizumab with onartuzumab versus placebo in patients with metastatic colorectal cancer (mCRC) [abstract]
doi: 10.4161/auto.25063